> top > docs > PMC:7299399 > spans > 20800-21435 > annotations

PMC:7299399 / 20800-21435 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T94 146-151 Body_part denotes lungs http://purl.org/sig/ont/fma/fma68877
T95 215-219 Body_part denotes lung http://purl.org/sig/ont/fma/fma7195
T96 530-537 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257

LitCovid-PD-UBERON

Id Subject Object Predicate Lexical cue uberon_id
T27 215-219 Body_part denotes lung http://purl.obolibrary.org/obo/UBERON_0002048

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T75 34-44 Disease denotes infections http://purl.obolibrary.org/obo/MONDO_0005550
T76 188-207 Disease denotes respiratory disease http://purl.obolibrary.org/obo/MONDO_0005087
T77 513-521 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T78 539-542 Disease denotes Ad5 http://purl.obolibrary.org/obo/MONDO_0011194

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T210 107-112 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T211 146-151 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lungs
T212 215-219 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
T213 215-219 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lung
T214 247-254 http://purl.obolibrary.org/obo/NCBITaxon_33208 denotes animals
T215 269-270 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T216 426-427 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T217 568-574 http://purl.obolibrary.org/obo/UBERON_0000473 denotes tested

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T133 530-537 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T134 586-588 Chemical denotes II http://purl.obolibrary.org/obo/CHEBI_74067

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T91 0-635 Sentence denotes The vaccine was unable to prevent infections, although it reduced the severity of the disease: no signs of virus replication were observed in the lungs, with significantly lower levels of respiratory disease and no lung damage compared to control animals, according to a recent article deposited in bioRxiv.69 Another adenoviral vector vaccine developed by CanSino Biological Inc. and Beijing Institute of Biotechnology using a genetically engineered replication-defective adenovirus type 5 vector to express the SARS-CoV-2 spike protein (Ad5-nCoV) is currently being tested in Phase I/II trials (NCT04398147, NCT04341389, NCT0431312).

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
308 539-542 Gene denotes Ad5 Gene:8081
309 524-529 Gene denotes spike Gene:43740568
311 578-588 Gene denotes Phase I/II
318 473-490 Species denotes adenovirus type 5 Tax:28285
319 513-523 Species denotes SARS-CoV-2 Tax:2697049
320 543-547 Species denotes nCoV Tax:2697049
322 34-44 Disease denotes infections MESH:D007239
323 188-207 Disease denotes respiratory disease MESH:D012140